Universitätsklinikum Münster

Long term outcomes of immunomodulatory drugs in SSc-ILD - data from the German SSc-network (2019) Kreuter M, Bonella F, Blank N, Siegert E, Henes J, Worm M, Sunderkoetter C, et al. Conference contribution A Multi-Platform Treatment Planning Benchmark Study for Spinal Radiosurgery (2019) Moustakis C, Chan MKH, Kim J, Nilsson J, Bergman A, Bichay TJ, Cilla S, et al. Conference contribution Characterization of Patients with inoperable malignant Stage IIIB-D Melanoma (2019) Zaremba A, Weishaupt C, Glutsch V, Schilling B, Loquai C, Rafei-Shamsabadi D, Meiss F, et al. Conference contribution The German National Registry of Primary Immunodeficiencies (2012-2017) (2019) El-Helou SM, Biegner AK, Bode S, Ehl SR, Heeg M, Maccari ME, Ritterbusch H, et al. Journal article Intratumoral RNA-based TLR-7/-8 and RIG-I agonist CV8102 alone and in combination with anti-PD-1 in a Phase I dose-escalation and expansion trial in patients with advanced solid tumors (2019) Eigentler T, Krauss J, Schreiber J, Weishaupt C, Terheyden P, Heinzerling L, Mohr P, et al. Conference contribution Optische Kohärenztomographie-Angiographie: Stellenwert in der Glaukomdiagnostik (2019) Alnawaiseh M, Lahme L, Eter N, Mardin C Journal article, Review article Favorable radiation field decrease in gastric marginal zone lymphoma Experience of the German Study Group on Gastrointestinal Lymphoma (DSGL) (2019) Reinartz G, Pyra RP, Lenz G, Liersch R, Stueben G, Micke O, Willborn K, et al. Journal article Identification of novel MRGX2-agonists triggering mast cell degranulation and potentially mediating drug-induced pruritus (2019) Kühn H, Wolf K, Boehm F, Glaudo M, Gebhardt L, Ectors P, Agelopoulos K, et al. Conference contribution Papillary glioneuronal tumor (PGNT) exhibits a characteristic methylation profile and fusions involving PRKCA (2019) Hou Y, Pinheiro J, Sahm F, Reuss DE, Schrimpf D, Stichel D, Casalini B, et al. Journal article Impfen bei Immundefizienz : Anwendungshinweise zu den von der Ständigen Impfkommission empfohlenen Impfungen. (IV) Impfen bei Autoimmunkrankheiten, bei anderen chronisch-entzündlichen Erkrankungen und unter immunmodulatorischer Therapie (2019) Wagner N, Assmus F, Arendt G, Baum E, Baumann U, Bogdan C, Burchard G, et al. Journal article